feruloyl-CoA(4-) : An acyl-CoA(4-) that is the tetraanion of feruloyl-CoA arising from deprotonation of the phosphate and diphosphate OH groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
trans-feruloyl-CoA(4-) : An acyl-CoA(4-) obtained by deprotonation of the phosphate and diphosphate OH groups of 3-trans-feruloyl-CoA. Major structure at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| ID Source | ID |
|---|---|
| PubMed CID | 44229137 |
| CHEBI ID | 57276 |
| CHEBI ID | 87305 |
| MeSH ID | M0305189 |
| Synonym |
|---|
| feruloyl-coa tetraanion |
| CHEBI:57276 |
| feruloyl-coa(4-) |
| feruloyl-coenzyme a(4-) |
| 3'-phosphonatoadenosine 5'-{3-[(3r)-3-hydroxy-4-({3-[(2-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]sulfanyl}ethyl)amino]-3-oxopropyl}amino)-2,2-dimethyl-4-oxobutyl] diphosphate} |
| 4-hydroxy-3-methoxycinnamoyl-coa(4-) |
| feruloyl-coa , |
| (e)-4-hydroxy-3-methoxycinnamoyl-coa |
| (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl-coa |
| trans-feruloyl-coa(4-) |
| trans-4-hydroxy-3-methoxycinnamoyl-coa(4-) |
| CHEBI:87305 |
| (e)-feruloyl-coa |
| trans-feruloyl-coenzyme a(4-) |
| (e)-feruloyl-coa(4-) |
| (e)-feruloyl-coenzyme a(4-) |
| trans-4-hydroxy-3-methoxycinnamoyl-coenzyme a(4-) |
| LMFA07050319 |
| Q27159512 |
| Class | Description |
|---|---|
| feruloyl-CoA(4-) | An acyl-CoA(4-) that is the tetraanion of feruloyl-CoA arising from deprotonation of the phosphate and diphosphate OH groups. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 10 (47.62) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 5 (23.81) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (26.64) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 21 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||